Medical Device News Magazine

Jeffery W Chambers MD Appointed CMO of Cardiovascular Systems

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Jeffery W Chambers MD is the new Chief Medical Officer at Cardiovascular Systems.

“CSI is developing an exciting product pipeline that targets some of the fastest growing segments of interventional cardiology,” said Scott Ward, Chairman, President and Chief Executive Officer. “Jeff brings contemporary interventional cardiology practice and extensive clinical research experience to CSI as we seek to expand our product offering beyond orbital atherectomy. We believe Jeff brings valuable perspective to CSI as we seek to successfully develop and commercialize everolimus drug coated balloons, intravascular lithotripsy balloons, thrombectomy devices and mechanical circulatory support products.”

Said Chambers, “I am excited to join CSI and I look forward to working with the team to bring innovative and important technologies to underserved patient populations. In doing so, together, we will improve the health of people with coronary and peripheral artery disease and fulfill our Mission.”

Jeffrey W Chambers MD was the primary investigator for the ORBIT II study, which served as the pivotal trial supporting the premarket approval for the use of orbital atherectomy in coronary arteries. In addition, he has served as a consultant in connection with CSI’s product development, quality assurance, medical affairs and clinical research.

Dr. Chambers received his medical degree from Wayne State University and completed his residency in Internal Medicine and fellowships in cardiovascular disease and interventional cardiology at the University of Minnesota. He has been employed at the Metropolitan Heart and Vascular Institute since 1995. Dr. Chambers is a serial entrepreneur with numerous issued patents, some of which are associated with devices commercially available today. He is a Fellow at The American College of Cardiology and is a member of The Society for Cardiovascular Angiography and Interventions.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”